|
C10ORF78 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6269208202857E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.8150372577993E-13 |
| Normal-vs-Stage2 |
3.85499965283032E-10 |
| Normal-vs-Stage3 |
2.34539998533734E-09 |
| Normal-vs-Stage4 |
3.20199422532141E-12 |
| Stage1-vs-Stage2 |
4.352500E-02 |
| Stage1-vs-Stage3 |
6.704000E-01 |
| Stage1-vs-Stage4 |
1.830210E-02 |
| Stage2-vs-Stage3 |
4.103700E-02 |
| Stage2-vs-Stage4 |
7.388600E-01 |
| Stage3-vs-Stage4 |
2.171900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34336985979644E-14 |
| Normal-vs-AfricanAmerican |
1.016790E-03 |
| Normal-vs-Asian |
1.64919999878776E-08 |
| Caucasian-vs-AfricanAmerican |
4.519200E-01 |
| Caucasian-vs-Asian |
6.513800E-01 |
| AfricanAmerican-vs-Asian |
6.050200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.27169974340325E-10 |
| Normal-vs-Female |
1.62647673107585E-12 |
| Male-vs-Female |
4.284400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97729610462716E-11 |
| Normal-vs-Age(41-60Yrs) |
5.4811710725744E-13 |
| Normal-vs-Age(61-80Yrs) |
5.34510213867634E-11 |
| Normal-vs-Age(81-100Yrs) |
2.574600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.765800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.128400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.989400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.676000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.510620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.088390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.507200E-01 |
| Classical-VS-Follicular |
6.21509999999548E-05 |
| Classical-VS-Other |
4.812400E-01 |
| Classical-VS-Normal |
1.56249999605507E-08 |
| Tall-VS-Follicular |
1.396400E-02 |
| Tall-VS-Other |
5.671600E-01 |
| Tall-VS-Normal |
1.769520E-04 |
| Follicular-VS-Other |
1.860230E-01 |
| Follicular-VS-Normal |
1.85063075974767E-12 |
| Other-VS-Normal |
2.271000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.56381590904675E-14 |
| Normal-vs-N1 |
1.08310005408896E-09 |
| N0-vs-N1 |
5.498400E-01 |
|
|
